Sylvia K Plevritis
Overview
Explore the profile of Sylvia K Plevritis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
122
Citations
9613
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Alagoz O, Caswell-Jin J, de Koning H, Huang H, Huang X, Lee S, et al.
J Breast Imaging
. 2025 Mar;
PMID: 40036318
The National Cancer Institute-funded Cancer Intervention and Surveillance Modeling Network (CISNET) breast cancer mathematical models have been increasingly utilized by policymakers to address breast cancer screening policy decisions and influence...
2.
Bouchard G, Zhang W, Ilerten I, Li I, Bhattacharya A, Li Y, et al.
Nat Commun
. 2025 Feb;
16(1):1392.
PMID: 39915493
Spatial omics is enabling unprecedented tissue characterization, but the ability to adequately compare spatial features across samples under different conditions is lacking. We propose a quantitative framework that catalogs significant,...
3.
Garcia M, Yeh C, Godfrey B, Perez P, Barisano G, Varma S, et al.
bioRxiv
. 2025 Jan;
PMID: 39868142
Brain metastases (BrMets), common for advanced-stage breast cancer patients, are associated with poor median survival and accompanied by severe neurologic decline. Halting the progression of breast cancer brain metastases (BCBMs)...
4.
Goddard K, Feuer E, Mandelblatt J, Meza R, Holford T, Jeon J, et al.
JAMA Oncol
. 2024 Dec;
11(2):162-167.
PMID: 39636625
Importance: Cancer mortality has decreased over time, but the contributions of different interventions across the cancer control continuum to averting cancer deaths have not been systematically evaluated across major cancer...
5.
Li N, Zhang W, Haensel D, Jussila A, Pan C, Gaddam S, et al.
Nat Commun
. 2024 Sep;
15(1):8134.
PMID: 39289380
Cancer-associated inflammation is a double-edged sword possessing both pro- and anti-tumor properties through ill-defined tumor-immune dynamics. While we previously identified a carcinoma tumor-intrinsic resistance pathway, basal-to-squamous cell carcinoma transition, here,...
6.
Yeh C, Aguirre K, Laveroni O, Kim S, Wang A, Liang B, et al.
Nat Immunol
. 2024 Aug;
25(10):1943-1958.
PMID: 39179931
The drivers of immune evasion are not entirely clear, limiting the success of cancer immunotherapies. Here we applied single-cell spatial and perturbational transcriptomics to delineate immune evasion in high-grade serous...
7.
Ten Haaf K, de Nijs K, Simoni G, Alban A, Cao P, Sun Z, et al.
Med Decis Making
. 2024 May;
44(5):497-511.
PMID: 38738534
Background: Recommendations regarding personalized lung cancer screening are being informed by natural-history modeling. Therefore, understanding how differences in model assumptions affect model-based personalized screening recommendations is essential. Design: Five Cancer...
8.
Trentham-Dietz A, Hunter Chapman C, Jayasekera J, Lowry K, Heckman-Stoddard B, Hampton J, et al.
JAMA
. 2024 Apr;
331(22):1947-1960.
PMID: 38687505
Importance: The effects of breast cancer incidence changes and advances in screening and treatment on outcomes of different screening strategies are not well known. Objective: To estimate outcomes of various...
9.
Caswell-Jin J, Kurian A, Plevritis S
JAMA
. 2024 Apr;
331(19):1679-1680.
PMID: 38662394
No abstract available.
10.
Caswell-Jin J, Sun L, Munoz D, Lu Y, Li Y, Huang H, et al.
JAMA
. 2024 Jan;
331(3):233-241.
PMID: 38227031
Importance: Breast cancer mortality in the US declined between 1975 and 2019. The association of changes in metastatic breast cancer treatment with improved breast cancer mortality is unclear. Objective: To...